| AXIN2 |
Homo sapiens |
|
AXIN2 is differentially expressed in 49 experiments [69 up/68 dn]: 18 organism parts: cerebellum [1 up/0 dn], white blood cells [0 up/1 dn], ...; 17 disease states: normal [5 up/2 dn], glioblastoma [0 up/2 dn], ...; 14 cell types, 19 cell lines, 12 compound treatments and 11 other conditions. |
| AXIN2, DKFZp781B0869 |
|
axin2 (Danio rerio)
Axin2 (Mus musculus)
AXN2_RAT (Rattus norvegicus)
(Compare orthologs)
|
|
|
| Axin beta-catenin binding, DIX, Regulator of G protein signalling, Regulator of G protein signalling superfamily |
|
|
| Colorectal cancer, Oligodontia-colorectal cancer syndrome |
|
|
| Wnt receptor signaling pathway, beta-catenin binding, cell death, intracellular, negative regulation of Wnt receptor signaling pathway |
|
|
|
Q5H9R8
Q9BRF5
Q9Y2T1
|
|
|
|
ENSG00000168646
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Stromal cell
|
Cell type |
|
|
FLAP
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
Not applicable
|
Histology |
|
|
Cystic change
|
Histology |
|
|
Glioblastoma
|
Disease state |
|
|
HeLa
|
Cell line |
|
|
Epithelial cell
|
Cell type |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Breast carcinoma
|
Disease state |
|
|
Normal
|
Histology |
|
|
N/a
|
Test result |
|
|
Cerebellum
|
Organism part |
|
|
MCF-7
|
Cell line |
|
|
AGS
|
Cell line |
|
|
White blood cells
|
Organism part |
|
|
Caudate nucleus
|
Organism part |
|
|
Cigarette smoke
|
Growth condition |
|
|
Incubator control
|
Growth condition |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
10 ng/ml LPS in media
|
Growth condition |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
PC3
|
Cell line |
|
|
Metastatic
|
Disease staging |
|
|
Media only
|
Growth condition |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Beas2B
|
Cell line |
|
|
Spermatid
|
Cell type |
|
|
YCC3
|
Cell line |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Cigarette smoke
|
Compound treatment |
|
|
MDA-MB-231
|
Cell line |
|
|
Grade IV
|
Tumor grading |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Chondrocyte
|
Cell type |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
Mannitol
|
Compound treatment |
|
|
Osteoblast
|
Cell type |
|
|
Met5A
|
Cell line |
|
|
Testis
|
Organism part |
|
|
Macaca mulatta
|
Organism |
|
|
Ischemic cardiomyopathy
|
Disease state |
|
|
Primary
|
Disease staging |
|
|
Filtered air
|
Compound treatment |
|
|
Colorectal adenocarcinoma
|
Disease state |
|
|
Spermatocyte
|
Cell type |
|
|
Fu97
|
Cell line |
|
|
Skeletal muscle
|
Organism part |
|
|
A549
|
Cell line |
|
|
HTERT/HPVE6/HPVE7/SV40t transf...
|
Gene modification |
|
|
Poorly differentiated gastric ...
|
Disease state |
|
|
Uninfected
|
Infection |
|
|
Term
|
Developmental stage |
|
|
Midgestation
|
Developmental stage |
|
|
Pancreatic cancer
|
Disease state |
|
|
CD3int CD4+ CD8+
|
Phenotype |
|
|
Double positive thymocyte
|
Cell type |
|
|
None
|
Compound treatment |
|
|
Granulocyte-colony stimulating...
|
Compound treatment |
|
|
MKN45
|
Cell line |
|
|
MKN28
|
Cell line |
|
|
HTERT/HPVE6/HPVE7/SV40t/hRas t...
|
Gene modification |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
TMK1
|
Cell line |
|
|
Seminiferous tubule
|
Organism part |
|
|
PT4a
|
Disease staging |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Adipose-derived stem cell
|
Cell type |
|
|
Lung
|
Organism part |
|
|
CD3high CD4+ CD8-
|
Phenotype |
|
|
Single positive thymocyte
|
Cell type |
|
|
AZ521
|
Cell line |
|
|
Cartilage
|
Organism part |
|
|
Homo sapiens
|
Organism |
|
|
Thymus
|
Organism part |
|
|
CD3- CD4+ CD8-
|
Phenotype |
|
|
Intrathymic T progenitor cell
|
Cell type |
|
|
Johnsen score count 7: many ea...
|
Histology |
|
|
Molecular class type 1
|
Test result |
|
|
Molecular class type 2
|
Test result |
|
|
Astrocyte
|
Cell type |
|
|
Benign
|
Disease staging |
|
|
Atrioventricular node
|
Organism part |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
A. fumigatus condia in media
|
Growth condition |
|
|
Ciliary ganglion
|
Organism part |
|
|
Vulvar intraepithelial neoplas...
|
Disease state |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
NCI-N87
|
Cell line |
|
|
Bone marrow
|
Organism part |
|
|
SNU5
|
Cell line |
|
|
Whole blood
|
Organism part |
|
|
HTERT/HPVE6/HPVE7 transfection
|
Gene modification |
|
|
Endothelial cell
|
Cell type |
|
|
Pan troglodytes
|
Organism |
|
|
KatoIII
|
Cell line |
|
|
Grade II
|
Tumor grading |
|
|
None
|
Gene modification |
|
|
Severe inflammation
|
Disease staging |
|
|
Tumor
|
Organism part |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Superior cervical ganglion
|
Organism part |
|
|
Actinomycin D
|
Compound treatment |
|
|
Rosiglitazone
|
Compound treatment |
|
|
4 cm away from the tumor bound...
|
Observation |
|
|
Epilepsy
|
Disease state |
|
|
|
|
|
Processing time: 0.099 secs.